Johnson & Johnson has underperformed its large-cap healthcare peers and the S&P 500, with an -8% decline over the past year.
In a report released today, Tim Anderson from Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research ...
Johnson & Johnson (NYSE: JNJ) stock is up 1.8% in the five days after the company announced its $14.6 billion acquisition of ...
Intra-Cellular Therapies makes Caplyta, a once-daily pill for adults with schizophrenia and bipolar-related depression ...
Johnson & Johnson (NYSE:JNJ), a global healthcare leader, finds itself at a pivotal juncture as it navigates a landscape of ...
Mayor Brandon Johnson’s latest campaign finance reports suggest ongoing issues with sloppy clerical work as well as ...
The Las Vegas Raiders have cycled through quarterbacks for most of the past two seasons, as they have been unsuccessful in finding a consistent option at the po ...
The 2024 regular season was a tough one for the New York Giants, who finished with a 3-14 record and the No. 3 overall pick ...